Our data demonstrate that defects in antigen presentation may be an important feature in predicting outcomes to ICB in both lung cancer and melanoma.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: